The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immunological Agents Market Research Report 2025

Global Immunological Agents Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1724886

No of Pages : 107

Ask Your Query

Synopsis
Highlights
The global Immunological Agents market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Immunological Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Immunological Agents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Immunological Agents in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Immunological Agents include Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Antirheumatic Drugs (DMARDs), which accounted for % of the global market of Immunological Agents in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Immunological Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunological Agents.
The Immunological Agents market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Immunological Agents market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunological Agents companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • Abbott
  • Organon
  • Pfizer
  • Sandoz
  • Amneal Pharmaceuticals
  • Apotex
  • Teva Pharmaceuticals
  • Biocon
  • Bristol Myers Squibb
  • Merck
  • CSL Behring
  • Sanofi
  • Leading Pharma
  • Accord Healthcare Inc
  • Amgen
  • Nabi Biopharmaceuticals
  • Ascend Laboratories
  • Camber Pharmaceuticals Inc
  • Grifols USA
  • JOM Pharmaceuticals

Product Type Insights
Global markets are presented by Immunological Agents type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Immunological Agents are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Immunological Agents segment by Type

  • Antirheumatic Drugs (DMARDs)
  • Immune Globulins
  • Immunomodulatory Agents
  • Immunosuppressive Agents
  • Monoclonal Antibodies
  • Other

Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Immunological Agents market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Immunological Agents market.
Immunological Agents Segment by Application

  • Hospital
  • Clinics
  • Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Immunological Agents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunological Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Immunological Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Immunological Agents industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunological Agents.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunological Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunological Agents Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antirheumatic Drugs (DMARDs)
1.2.3 Immune Globulins
1.2.4 Immunomodulatory Agents
1.2.5 Immunosuppressive Agents
1.2.6 Monoclonal Antibodies
1.2.7 Other
1.3 Market by Application
1.3.1 Global Immunological Agents Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunological Agents Market Perspective (2017-2028)
2.2 Immunological Agents Growth Trends by Region
2.2.1 Immunological Agents Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immunological Agents Historic Market Size by Region (2017-2022)
2.2.3 Immunological Agents Forecasted Market Size by Region (2023-2028)
2.3 Immunological Agents Market Dynamics
2.3.1 Immunological Agents Industry Trends
2.3.2 Immunological Agents Market Drivers
2.3.3 Immunological Agents Market Challenges
2.3.4 Immunological Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunological Agents Players by Revenue
3.1.1 Global Top Immunological Agents Players by Revenue (2017-2022)
3.1.2 Global Immunological Agents Revenue Market Share by Players (2017-2022)
3.2 Global Immunological Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunological Agents Revenue
3.4 Global Immunological Agents Market Concentration Ratio
3.4.1 Global Immunological Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunological Agents Revenue in 2021
3.5 Immunological Agents Key Players Head office and Area Served
3.6 Key Players Immunological Agents Product Solution and Service
3.7 Date of Enter into Immunological Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunological Agents Breakdown Data by Type
4.1 Global Immunological Agents Historic Market Size by Type (2017-2022)
4.2 Global Immunological Agents Forecasted Market Size by Type (2023-2028)
5 Immunological Agents Breakdown Data by Application
5.1 Global Immunological Agents Historic Market Size by Application (2017-2022)
5.2 Global Immunological Agents Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immunological Agents Market Size (2017-2028)
6.2 North America Immunological Agents Market Size by Country (2017-2022)
6.3 North America Immunological Agents Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Immunological Agents Market Size (2017-2028)
7.2 Europe Immunological Agents Market Size by Country (2017-2022)
7.3 Europe Immunological Agents Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunological Agents Market Size (2017-2028)
8.2 Asia-Pacific Immunological Agents Market Size by Country (2017-2022)
8.3 Asia-Pacific Immunological Agents Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Immunological Agents Market Size (2017-2028)
9.2 Latin America Immunological Agents Market Size by Country (2017-2022)
9.3 Latin America Immunological Agents Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunological Agents Market Size (2017-2028)
10.2 Middle East & Africa Immunological Agents Market Size by Country (2017-2022)
10.3 Middle East & Africa Immunological Agents Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Immunological Agents Introduction
11.1.4 Abbott Revenue in Immunological Agents Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 Organon
11.2.1 Organon Company Detail
11.2.2 Organon Business Overview
11.2.3 Organon Immunological Agents Introduction
11.2.4 Organon Revenue in Immunological Agents Business (2017-2022)
11.2.5 Organon Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Immunological Agents Introduction
11.3.4 Pfizer Revenue in Immunological Agents Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Sandoz
11.4.1 Sandoz Company Detail
11.4.2 Sandoz Business Overview
11.4.3 Sandoz Immunological Agents Introduction
11.4.4 Sandoz Revenue in Immunological Agents Business (2017-2022)
11.4.5 Sandoz Recent Development
11.5 Amneal Pharmaceuticals
11.5.1 Amneal Pharmaceuticals Company Detail
11.5.2 Amneal Pharmaceuticals Business Overview
11.5.3 Amneal Pharmaceuticals Immunological Agents Introduction
11.5.4 Amneal Pharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.5.5 Amneal Pharmaceuticals Recent Development
11.6 Apotex
11.6.1 Apotex Company Detail
11.6.2 Apotex Business Overview
11.6.3 Apotex Immunological Agents Introduction
11.6.4 Apotex Revenue in Immunological Agents Business (2017-2022)
11.6.5 Apotex Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Detail
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Immunological Agents Introduction
11.7.4 Teva Pharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Biocon
11.8.1 Biocon Company Detail
11.8.2 Biocon Business Overview
11.8.3 Biocon Immunological Agents Introduction
11.8.4 Biocon Revenue in Immunological Agents Business (2017-2022)
11.8.5 Biocon Recent Development
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Detail
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Immunological Agents Introduction
11.9.4 Bristol Myers Squibb Revenue in Immunological Agents Business (2017-2022)
11.9.5 Bristol Myers Squibb Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Immunological Agents Introduction
11.10.4 Merck Revenue in Immunological Agents Business (2017-2022)
11.10.5 Merck Recent Development
11.11 CSL Behring
11.11.1 CSL Behring Company Detail
11.11.2 CSL Behring Business Overview
11.11.3 CSL Behring Immunological Agents Introduction
11.11.4 CSL Behring Revenue in Immunological Agents Business (2017-2022)
11.11.5 CSL Behring Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Immunological Agents Introduction
11.12.4 Sanofi Revenue in Immunological Agents Business (2017-2022)
11.12.5 Sanofi Recent Development
11.13 Leading Pharma
11.13.1 Leading Pharma Company Detail
11.13.2 Leading Pharma Business Overview
11.13.3 Leading Pharma Immunological Agents Introduction
11.13.4 Leading Pharma Revenue in Immunological Agents Business (2017-2022)
11.13.5 Leading Pharma Recent Development
11.14 Accord Healthcare Inc
11.14.1 Accord Healthcare Inc Company Detail
11.14.2 Accord Healthcare Inc Business Overview
11.14.3 Accord Healthcare Inc Immunological Agents Introduction
11.14.4 Accord Healthcare Inc Revenue in Immunological Agents Business (2017-2022)
11.14.5 Accord Healthcare Inc Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Immunological Agents Introduction
11.15.4 Amgen Revenue in Immunological Agents Business (2017-2022)
11.15.5 Amgen Recent Development
11.16 Nabi Biopharmaceuticals
11.16.1 Nabi Biopharmaceuticals Company Detail
11.16.2 Nabi Biopharmaceuticals Business Overview
11.16.3 Nabi Biopharmaceuticals Immunological Agents Introduction
11.16.4 Nabi Biopharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.16.5 Nabi Biopharmaceuticals Recent Development
11.17 Ascend Laboratories
11.17.1 Ascend Laboratories Company Detail
11.17.2 Ascend Laboratories Business Overview
11.17.3 Ascend Laboratories Immunological Agents Introduction
11.17.4 Ascend Laboratories Revenue in Immunological Agents Business (2017-2022)
11.17.5 Ascend Laboratories Recent Development
11.18 Camber Pharmaceuticals Inc
11.18.1 Camber Pharmaceuticals Inc Company Detail
11.18.2 Camber Pharmaceuticals Inc Business Overview
11.18.3 Camber Pharmaceuticals Inc Immunological Agents Introduction
11.18.4 Camber Pharmaceuticals Inc Revenue in Immunological Agents Business (2017-2022)
11.18.5 Camber Pharmaceuticals Inc Recent Development
11.19 Grifols USA
11.19.1 Grifols USA Company Detail
11.19.2 Grifols USA Business Overview
11.19.3 Grifols USA Immunological Agents Introduction
11.19.4 Grifols USA Revenue in Immunological Agents Business (2017-2022)
11.19.5 Grifols USA Recent Development
11.20 JOM Pharmaceuticals
11.20.1 JOM Pharmaceuticals Company Detail
11.20.2 JOM Pharmaceuticals Business Overview
11.20.3 JOM Pharmaceuticals Immunological Agents Introduction
11.20.4 JOM Pharmaceuticals Revenue in Immunological Agents Business (2017-2022)
11.20.5 JOM Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Immunological Agents Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Antirheumatic Drugs (DMARDs)
Table 3. Key Players of Immune Globulins
Table 4. Key Players of Immunomodulatory Agents
Table 5. Key Players of Immunosuppressive Agents
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Other
Table 8. Global Immunological Agents Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Immunological Agents Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Immunological Agents Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Immunological Agents Market Share by Region (2017-2022)
Table 12. Global Immunological Agents Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Immunological Agents Market Share by Region (2023-2028)
Table 14. Immunological Agents Market Trends
Table 15. Immunological Agents Market Drivers
Table 16. Immunological Agents Market Challenges
Table 17. Immunological Agents Market Restraints
Table 18. Global Immunological Agents Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Immunological Agents Market Share by Players (2017-2022)
Table 20. Global Top Immunological Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunological Agents as of 2021)
Table 21. Ranking of Global Top Immunological Agents Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Immunological Agents Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Immunological Agents Product Solution and Service
Table 25. Date of Enter into Immunological Agents Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immunological Agents Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Immunological Agents Revenue Market Share by Type (2017-2022)
Table 29. Global Immunological Agents Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Immunological Agents Revenue Market Share by Type (2023-2028)
Table 31. Global Immunological Agents Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Immunological Agents Revenue Market Share by Application (2017-2022)
Table 33. Global Immunological Agents Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Immunological Agents Revenue Market Share by Application (2023-2028)
Table 35. North America Immunological Agents Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Immunological Agents Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Immunological Agents Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Immunological Agents Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Immunological Agents Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Immunological Agents Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Immunological Agents Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Immunological Agents Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Immunological Agents Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Immunological Agents Market Size by Country (2023-2028) & (US$ Million)
Table 45. Abbott Company Detail
Table 46. Abbott Business Overview
Table 47. Abbott Immunological Agents Product
Table 48. Abbott Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 49. Abbott Recent Development
Table 50. Organon Company Detail
Table 51. Organon Business Overview
Table 52. Organon Immunological Agents Product
Table 53. Organon Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 54. Organon Recent Development
Table 55. Pfizer Company Detail
Table 56. Pfizer Business Overview
Table 57. Pfizer Immunological Agents Product
Table 58. Pfizer Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 59. Pfizer Recent Development
Table 60. Sandoz Company Detail
Table 61. Sandoz Business Overview
Table 62. Sandoz Immunological Agents Product
Table 63. Sandoz Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 64. Sandoz Recent Development
Table 65. Amneal Pharmaceuticals Company Detail
Table 66. Amneal Pharmaceuticals Business Overview
Table 67. Amneal Pharmaceuticals Immunological Agents Product
Table 68. Amneal Pharmaceuticals Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 69. Amneal Pharmaceuticals Recent Development
Table 70. Apotex Company Detail
Table 71. Apotex Business Overview
Table 72. Apotex Immunological Agents Product
Table 73. Apotex Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 74. Apotex Recent Development
Table 75. Teva Pharmaceuticals Company Detail
Table 76. Teva Pharmaceuticals Business Overview
Table 77. Teva Pharmaceuticals Immunological Agents Product
Table 78. Teva Pharmaceuticals Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 79. Teva Pharmaceuticals Recent Development
Table 80. Biocon Company Detail
Table 81. Biocon Business Overview
Table 82. Biocon Immunological Agents Product
Table 83. Biocon Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 84. Biocon Recent Development
Table 85. Bristol Myers Squibb Company Detail
Table 86. Bristol Myers Squibb Business Overview
Table 87. Bristol Myers Squibb Immunological Agents Product
Table 88. Bristol Myers Squibb Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 89. Bristol Myers Squibb Recent Development
Table 90. Merck Company Detail
Table 91. Merck Business Overview
Table 92. Merck Immunological Agents Product
Table 93. Merck Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 94. Merck Recent Development
Table 95. CSL Behring Company Detail
Table 96. CSL Behring Business Overview
Table 97. CSL Behring Immunological AgentsProduct
Table 98. CSL Behring Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 99. CSL Behring Recent Development
Table 100. Sanofi Company Detail
Table 101. Sanofi Business Overview
Table 102. Sanofi Immunological AgentsProduct
Table 103. Sanofi Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. Leading Pharma Company Detail
Table 106. Leading Pharma Business Overview
Table 107. Leading Pharma Immunological AgentsProduct
Table 108. Leading Pharma Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 109. Leading Pharma Recent Development
Table 110. Accord Healthcare Inc Company Detail
Table 111. Accord Healthcare Inc Business Overview
Table 112. Accord Healthcare Inc Immunological AgentsProduct
Table 113. Accord Healthcare Inc Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 114. Accord Healthcare Inc Recent Development
Table 115. Amgen Company Detail
Table 116. Amgen Business Overview
Table 117. Amgen Immunological AgentsProduct
Table 118. Amgen Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 119. Amgen Recent Development
Table 120. Nabi Biopharmaceuticals Company Detail
Table 121. Nabi Biopharmaceuticals Business Overview
Table 122. Nabi Biopharmaceuticals Immunological AgentsProduct
Table 123. Nabi Biopharmaceuticals Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 124. Nabi Biopharmaceuticals Recent Development
Table 125. Ascend Laboratories Company Detail
Table 126. Ascend Laboratories Business Overview
Table 127. Ascend Laboratories Immunological AgentsProduct
Table 128. Ascend Laboratories Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 129. Ascend Laboratories Recent Development
Table 130. Camber Pharmaceuticals Inc Company Detail
Table 131. Camber Pharmaceuticals Inc Business Overview
Table 132. Camber Pharmaceuticals Inc Immunological AgentsProduct
Table 133. Camber Pharmaceuticals Inc Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 134. Camber Pharmaceuticals Inc Recent Development
Table 135. Grifols USA Company Detail
Table 136. Grifols USA Business Overview
Table 137. Grifols USA Immunological AgentsProduct
Table 138. Grifols USA Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 139. Grifols USA Recent Development
Table 140. JOM Pharmaceuticals Company Detail
Table 141. JOM Pharmaceuticals Business Overview
Table 142. JOM Pharmaceuticals Immunological AgentsProduct
Table 143. JOM Pharmaceuticals Revenue in Immunological Agents Business (2017-2022) & (US$ Million)
Table 144. JOM Pharmaceuticals Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunological Agents Market Share by Type: 2021 VS 2028
Figure 2. Antirheumatic Drugs (DMARDs) Features
Figure 3. Immune Globulins Features
Figure 4. Immunomodulatory Agents Features
Figure 5. Immunosuppressive Agents Features
Figure 6. Monoclonal Antibodies Features
Figure 7. Other Features
Figure 8. Global Immunological Agents Market Share by Application in 2021 & 2028
Figure 9. Hospital Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Immunological Agents Report Years Considered
Figure 13. Global Immunological Agents Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Immunological Agents Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Immunological Agents Market Share by Region: 2021 VS 2028
Figure 16. Global Immunological Agents Market Share by Players in 2021
Figure 17. Global Top Immunological Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunological Agents as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Immunological Agents Revenue in 2021
Figure 19. North America Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Immunological Agents Market Share by Country (2017-2028)
Figure 21. United States Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Immunological Agents Market Share by Country (2017-2028)
Figure 25. Germany Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Immunological Agents Market Share by Region (2017-2028)
Figure 33. China Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Immunological Agents Market Share by Country (2017-2028)
Figure 41. Mexico Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Immunological Agents Market Share by Country (2017-2028)
Figure 45. Turkey Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Immunological Agents Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Abbott Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 48. Organon Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 49. Pfizer Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 50. Sandoz Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 51. Amneal Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 52. Apotex Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 54. Biocon Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 55. Bristol Myers Squibb Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 56. Merck Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 57. CSL Behring Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 59. Leading Pharma Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 60. Accord Healthcare Inc Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 61. Amgen Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 62. Nabi Biopharmaceuticals Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 63. Ascend Laboratories Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 64. Camber Pharmaceuticals Inc Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 65. Grifols USA Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 66. JOM Pharmaceuticals Revenue Growth Rate in Immunological Agents Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock